Dev Prasad

Stock Analyst at LUCID CAPITAL MARKETS

(n/a)

# 4,625

Out of 4,831 analysts

3

Total ratings

n/a

Success rate

-50.85%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Dev Prasad

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	AVTX Avalo Therapeutics	Initiates: Buy	$24	$3.68	+552.17%	1	Dec 17, 2024
	IBIO iBio, Inc.	Initiates: Buy	$6	$0.80	+650.00%	1	Dec 17, 2024
	CALC CalciMedica	Initiates: Buy	$13	$1.93	+573.58%	1	Dec 17, 2024

Avalo Therapeutics

Dec 17, 2024

Initiates: Buy

Price Target: $24

Current: $3.68

Upside: +552.17%

iBio, Inc.

Dec 17, 2024

Initiates: Buy

Price Target: $6

Current: $0.80

Upside: +650.00%

CalciMedica

Dec 17, 2024

Initiates: Buy

Price Target: $13

Current: $1.93

Upside: +573.58%